# National Center for Research Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
*Name of Committee:* Scientific and Technical Review Board on Biomedical and Behavioral Research Facilities; STRB 08.
*Date:* September 24-25, 2008.
*Time:* 8 am to 5 pm.
*Agenda:* To review and evaluate grant applications.
*Place:* Hilton Washington/Rockville, Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852.
*Contact Person:* Barbara J. Nelson, PhD, Scientific Review Officer, National Center for Research Resources, or National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1080, MSC 4874, Bethesda, MD 20892-4874, 301-435-0806.
*Name of Committee:* National Center for Research Resources Initial Review Group, Clinical Research Review Committee, CTSA.
*Date:* September 24, 2008.
*Time:* 8 am to 5 pm.
*Agenda:* To review and evaluate grant applications.
*Place:* Hilton Washington DC/Rockville, Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852.
*Contact Person:* Mohan Viswanathan, PhD, Deputy Director, National Center for Research Resources, or National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1084, MSC 4874, Bethesda, MD 20892-4874, 301-435-0829, *[email protected].*
(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS)
Dated: July 23, 2003.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.